Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cytotherapy. 2017 Sep 13;19(12):1491–1500. doi: 10.1016/j.jcyt.2017.07.013

Figure 1.

Figure 1

Vaser and Lysonix lipoaspirates yield similar amounts of ASCs with comparable viability. (A): FACS analysis for identification of ASCs (defined as CD45−/CD31−/CD34+) of Vaser and Lysonix derived lipoaspirates; (B): CD45−/CD31−/CD34+ASC-quantification in Vaser and Lysonix derived SVF showed no significant difference in ASC yield across samples (C): MTT assay showed no significant difference in cell viability. n=3; data are given as mean ±SEM. Abbreviations: SVF: Stromal Vascular Fraction; ASC: Adipose derived Stromal Cells.